D-219-2013 Class III Terminated
FDA drug recall D-219-2013 was initiated by Pfizer Inc. on Nov 26, 2012 and is designated Class III. Reason for recall: Lack of Assurance of Sterility; potential that a low level of endotoxins may be present in the diluent vials. The recall status is terminated (terminated Mar 31, 2015). Affected quantity: 10920 kits.
Recall details
- Product Type
- Drugs
- Report Date
- Apr 3, 2013
- Initiation Date
- Nov 26, 2012
- Termination Date
- Mar 31, 2015
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 10920 kits
Product description
TORISEL Kit (temsirolimus) injection, 25 mg/mL, CONCENTRATED, Rx Only, Packaged in a carton containing 1 vial TORISEL injection and 1 vial DILUENT for TORISEL, Distributed by Wyeth Pharmaceuticals Inc., A subsidiary of Pfizer Inc., Philadelphia, PA --- NDC 0008-1179-01
Reason for recall
Lack of Assurance of Sterility; potential that a low level of endotoxins may be present in the diluent vials.
Distribution pattern
Nationwide
Code information
Lots P00025A; P00027B
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-219-2013
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026